Update on the Detection of Frailty in Older Adults
Launched by UNIVERSIDAD EUROPEA DE MADRID · Jan 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding frailty in older adults, which is a condition that can affect strength, quality of life, and the ability to function independently. Researchers aim to improve the ways frailty is diagnosed by using ultrasound images alongside other health measurements. They also want to gather information about how frailty impacts various aspects of life, including pain and mental health, to better support older adults in managing their health.
To participate in this study, individuals must be diagnosed with frailty by a geriatric doctor using specific assessment tools. However, certain conditions may exclude someone from joining, such as recent heart problems, severe pain, or significant cognitive difficulties. Those who are eligible will be closely monitored and can expect to contribute to valuable research that could lead to better treatment plans for frail older adults in the future. This is an important step toward enhancing the care and quality of life for seniors facing these challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A diagnosis of signs and symptoms of frailty by a geriatric physician in the research group will be used as the primary inclusion criterion. Frailty will be assessed and diagnosed using the frailty phenotype and the Clinical Frailty Scale.
- Exclusion Criteria:
- • Acute myocardial infarction in the last 3 months and/or unstable angina pectoris
- • Uncontrolled arrhythmia, recent thromboembolism and terminal illness.
- • Patients undergoing MMII unloading or MMSS/MMII fractures in the last three months.
- • Patients with a functional gait index of 1 (Inability to walk)
- • Severe pain (7/10 VAS)
- • Previous neuromuscular pathology presenting with weakness
- • Medication that does not allow the patient's actual muscle reaction to be assessed
- • Severe cognitive impairment that would prevent collaboration and understanding of the tests to be performed.
- • Cardiovascularly unstable patients and uncontrolled arterial hypertension.
About Universidad Europea De Madrid
Universidad Europea de Madrid (UEM) is a leading academic institution dedicated to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, UEM is committed to fostering innovative research that contributes to the understanding and improvement of medical practices. The university collaborates with healthcare professionals and researchers to design and implement rigorous clinical trials, ensuring adherence to ethical standards and regulatory guidelines. UEM's focus on interdisciplinary collaboration and cutting-edge research methodologies positions it as a pivotal player in the advancement of clinical knowledge and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, Outside Of The Us, Spain
Patients applied
Trial Officials
Eleuterio A. A. Sánchez Romero, PhD
Principal Investigator
European University of Madrid
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported